Commonwealth Bank of Australia’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-472
Closed -$39K 139
2019
Q2
$39K Buy
472
+122
+35% +$10.1K ﹤0.01% 1001
2019
Q1
$30K Hold
350
﹤0.01% 998
2018
Q4
$29K Buy
350
+116
+50% +$9.61K ﹤0.01% 994
2018
Q3
$21K Sell
234
-100
-30% -$8.97K ﹤0.01% 1057
2018
Q2
$30K Buy
334
+164
+96% +$14.7K ﹤0.01% 705
2018
Q1
$13K Hold
170
﹤0.01% 730
2017
Q4
$13K Sell
170
-2
-1% -$153 ﹤0.01% 749
2017
Q3
$14K Sell
172
-804
-82% -$65.4K ﹤0.01% 733
2017
Q2
$87K Buy
976
+172
+21% +$15.3K ﹤0.01% 732
2017
Q1
$70K Buy
804
+123
+18% +$10.7K ﹤0.01% 757
2016
Q4
$57K Sell
681
-130
-16% -$10.9K ﹤0.01% 748
2016
Q3
$76K Hold
811
﹤0.01% 686
2016
Q2
$63K Sell
811
-240
-23% -$18.6K ﹤0.01% 700
2016
Q1
$87K Buy
1,051
+259
+33% +$21.4K ﹤0.01% 651
2015
Q4
$83K Buy
792
+159
+25% +$16.7K ﹤0.01% 666
2015
Q3
$66K Buy
633
+208
+49% +$21.7K ﹤0.01% 695
2015
Q2
$58K Sell
425
-175
-29% -$23.9K ﹤0.01% 689
2015
Q1
$75K Sell
600
-200
-25% -$25K ﹤0.01% 621
2014
Q4
$72K Sell
800
-5,000
-86% -$450K ﹤0.01% 621
2014
Q3
$419K Sell
5,800
-200
-3% -$14.4K 0.01% 628
2014
Q2
$373K Sell
6,000
-49,183
-89% -$3.06M 0.01% 623
2014
Q1
$3.76M Sell
55,183
-1,380
-2% -$94.1K 0.02% 512
2013
Q4
$3.98M Sell
56,563
-240
-0.4% -$16.9K 0.03% 480
2013
Q3
$4.1M Sell
56,803
-5,007
-8% -$361K 0.03% 441
2013
Q2
$3.45M Buy
+61,810
New +$3.45M 0.03% 462